|
|
|
02 Jun 2006 |
Life Science Pharmaceuticals Acquires Three Clinical Stage Monoclonal Antibody Programs From the Ludwig Institute for Cancer Research
|
|
02 Jun 2006 |
Halozyme Therapeutics Presents Preclinical and Pharmacokinetic Data on the Subcutaneous Delivery of Antibodies With Enhanze Technology at the 2006 IBC Antibody Conference
|
|
01 Jun 2006 |
EvoGenix Announces Antibody Collaboration with CSL
|
|
01 Jun 2006 |
Results of TNX-355 Combination Study Published in Antimicrobial Agents and Chemotherapy
|
|
31 May 2006 |
KaloBios Collaborates to Engineer Human Antibody Therapeutic Drugs
|
|
31 May 2006 |
Millennium Announces MLN1202 Fully Met Primary Endpoint in Phase II Clinical Study of Patients at High Risk for Atherosclerosis
|
|
31 May 2006 |
Nabi Biopharmaceuticals Provides Regulatory Update on Hepatitis B Liver Transplant Programs
|
|
26 May 2006 |
Final report on TGN1412 clinical trial
|
|
26 May 2006 |
Genentech Submits Supplemental Biologics License Application for Avastin with Chemotherapy in First-Line Metastatic Breast Cancer
|
|
25 May 2006 |
Progenics Broadens Collaboration with Seattle Genetics for Prostate Cancer Therapy; Positive Preclinical Findings on PSMA Antibody-Drug Conjugate Published in Clinical Cancer Research Journal
|
|
25 May 2006 |
Peregrine Pharmaceuticals' Bavituximab Shows Potential Activity Against Avian Flu in Initial Testing
|
|
25 May 2006 |
New Data for Nuvion(R) Presented at Digestive Disease Week Conference
|
|
24 May 2006 |
XOMA and Schering-Plough Establish Collaboration for Therapeutic Antibody Discovery and Development
|
|
24 May 2006 |
Herceptin approved in Europe for early use in HER2-positive breast cancer
|
|
24 May 2006 |
Genmab Initiates Humax-CD20 CLL Pivotal Study
|
|
23 May 2006 |
First Patient Dosed in Phase 1 Trial of Tanox's TNX-650
|
|
23 May 2006 |
Recruitment to Resume in Avastin International Phase III Trial (AVANT) in Early-Stage Colon Cancer
|
|
23 May 2006 |
Dyax Corp. and ICOS Corporation Enter Into License Agreement for Discovery of Therapeutic Antibodies
|
|
23 May 2006 |
New CIMZIA™ Data from PRECiSE Program Reinforce Robust Efficacy in Once-Monthly Treatment of Crohn's Disease and Consistent Tolerability Profile
|
|
23 May 2006 |
Promising Pivotal Phase III Data Show Abbott's HUMIRA® (adalimumab) Maintained Clinical Remission in Patients with Crohn's Disease Through One Year
|
|
22 May 2006 |
Zenyth Receives Fourth Milestone Payment From Merck & Co., Inc. For Asthma Treatment
|
|
20 May 2006 |
FDA Approves Remicade for Children with Crohn’s Disease
|
|
17 May 2006 |
XOMA Establishes Development and Manufacturing Relationship with Taligen; XOMA to utilize its Bacterial Cell Expression Technology to Manufacture Novel Anti-Inflammatory Therapeutic for Clinical Trials
|
|
17 May 2006 |
MorphoSys and Schering-Plough Sign R&D Agreement
|
|
16 May 2006 |
AMG 714 Data To Be Presented At EULAR Conference
|
|
15 May 2006 |
ALEXION Pharmaceuticals’ Antibody Therapy Shown Effective in Model for Severe Allergic Asthma
|
|
12 May 2006 |
Strategic alliance with Merck to develop monoclonal antibodies to treat S. aureus infections
|
|
11 May 2006 |
Caprion Receives FDA Fast Track Designation for Shigamabs Clinical Program
|
|
11 May 2006 |
Oxford Genome Sciences and Medarex Sign Therapeutic Antibody Collaboration Agreement in Cancer
|
|
10 May 2006 |
UCB and Immunomedics announce worldwide development collaboration and license agreement for Epratuzumab
|
|
09 May 2006 |
Cytogen Announces FDA Clears IND for CYT-500, a Monoclonal Antibody for the Treatment of Metastatic Hormone-Refractory Prostate Cancer
|
|
06 May 2006 |
U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) Supplemental Biologics License Application (sBLA) for Third-Party Manufacturing Facility Lonza Biologics Inc.
|
|
05 May 2006 |
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech; Companies Also Amend 2000 Agreement for TAP Compounds Targeting HER2, Potentially Providing Increased Royalties and Milestones to ImmunoGen
|
|
04 May 2006 |
Seattle Genetics Reports on SGN-30 Cutaneous ALCL Phase II Clinical Trial at the Society of Investigative Dermatology Meeting
|
|
02 May 2006 |
Tanox Reports 48-Week Results from TNX-355 Phase 2 Clinical Trial
|
|
28 Apr 2006 |
Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion From European Medicines Agency for the Treatment of Ankylosing Spondylitis
|
|
28 Apr 2006 |
CHMP Issues Positive Opinion for TYSABRI® as a Treatment for Relapsing-Remitting Multiple Sclerosis
|
|
28 Apr 2006 |
UCB Submits Marketing Authorisation Application in Europe for CIMZIA (TM), a New Crohn’s Disease Therapy
|
|
27 Apr 2006 |
YM BioSciences' partner, Oncoscience AG, commences patient treatment in phase III trial in Germany with nimotuzumab
|
|
27 Apr 2006 |
XOMA and AVEO Announce Agreement to Apply Human Engineering™ Technology to AV-299, AVEO’s
|
|
25 Apr 2006 |
Chugai Pharmaceutical Files New Drug Application for Anti-tumor Agent Bevacizumab
|
|
25 Apr 2006 |
Epratuzumab for Immunotherapy of Lupus Results Published
|
|
21 Apr 2006 |
BioInvent and Immusol to collaborate on antibody therapeutic for macular degeneration
|
|
20 Apr 2006 |
MedImmune Licenses Elusys Therapeutics' Technology for Use in Developing New Therapies Targeting Infectious Disease
|
|
14 Apr 2006 |
MedImmune Begins Dosing of Lupus Patients in Phase 1 Clinical Trial
|
|
12 Apr 2006 |
Genentech Submits Supplemental Biologics License Application for Avastin with Chemotherapy in First-Line, Non-Squamous, Non-Small Cell Lung Cancer
|
|
12 Apr 2006 |
Biolex Therapeutics Announces Expansion Of Medarex Collaboration
|
|
11 Apr 2006 |
Additional Preclinical and Clinical Data Indicate Abegrin(TM) May Offer Three-Pronged Approach to Cancer Therapy
|
|
11 Apr 2006 |
InNexus Biotechnology and Affimed Therapeutics AG to Collaborate; Will Use SuperAntibody Technology to Target Multiple Cancers
|
|
07 Apr 2006 |
New Data on TYSABRI(R) Demonstrate Significant Effects on Health-Related Quality of Life Measures in Patients with Multiple Sclerosis
|
| |
|
Results 1001 - 1050 of 1155 |